DK Technical Analysis by Dhananjay Kadam
Contact- @dsk4u We are EQUITY RESEARCH ANALYST, Financial Advisor, TRAINER, Trader, Blogger. Providing various types of calls and Market related Information, updation in channel.All are for educational purposes only. Perfect Charting Is An Art 🍎🍎🍎🍎🍎
Ko'proq ko'rsatish📈 Telegram kanali DK Technical Analysis by Dhananjay Kadam analitikasi
DK Technical Analysis by Dhananjay Kadam (@dktechnicals) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 28 262 obunachidan iborat bo'lib, Iqtisodiyot & Moliya toifasida 4 359-o'rinni va Hindiston mintaqasida 14 757-o'rinni egallagan.
📊 Auditoriya ko‘rsatkichlari va dinamika
невідомо sanasidan buyon loyiha tez o‘sib, 28 262 obunachiga ega bo‘ldi.
26 Iyul, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni -73 ga, so‘nggi 24 soatda esa 0 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.
- Tasdiqlash holati: Tasdiqlanmagan
- Jalb etish (ER): Auditoriya o‘rtacha 13.16% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 10.19% ini tashkil etuvchi reaksiyalarni to‘playdi.
- Post qamrovi: Har bir post o‘rtacha 3 719 marta ko‘riladi; birinchi sutkada odatda 2 880 ta ko‘rish yig‘iladi.
- Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 0 ta reaksiya keladi.
- Tematik yo‘nalishlar: Kontent crore, yoy, revenue, margin, inr kabi asosiy mavzularga jamlangan.
📝 Tavsif va kontent siyosati
Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“Contact- @dsk4u We are EQUITY RESEARCH ANALYST, Financial Advisor, TRAINER, Trader, Blogger. Providing various types of calls and Market related Information, updation in channel.All are for educational purposes only.
Perfect Charting Is An Art 🍎🍎�...”
Yuqori yangilanish chastotasi (oxirgi ma’lumot 27 Iyul, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Iqtisodiyot & Moliya toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.
Ma'lumot yuklanmoqda...
| Sana | Obunachilarni jalb qilish | Esdaliklar | Kanallar | |
| 27 Iyul | 0 | |||
| 26 Iyul | +1 | |||
| 25 Iyul | 0 | |||
| 24 Iyul | 0 | |||
| 23 Iyul | +1 | |||
| 22 Iyul | +1 | |||
| 21 Iyul | +1 | |||
| 20 Iyul | 0 | |||
| 19 Iyul | +3 | |||
| 18 Iyul | 0 | |||
| 17 Iyul | 0 | |||
| 16 Iyul | +1 | |||
| 15 Iyul | +2 | |||
| 14 Iyul | +1 | |||
| 13 Iyul | +7 | |||
| 12 Iyul | +3 | |||
| 11 Iyul | +13 | |||
| 10 Iyul | +4 | |||
| 09 Iyul | 0 | |||
| 08 Iyul | +7 | |||
| 07 Iyul | 0 | |||
| 06 Iyul | +13 | |||
| 05 Iyul | +6 | |||
| 04 Iyul | +6 | |||
| 03 Iyul | +12 | |||
| 02 Iyul | 0 | |||
| 01 Iyul | +8 |
| 2 |  MARINE 😍😘 | 2 266 |
| 3 | SENORES PHARMA: Q1 CONS NET PROFIT 307M RUPEES VS 197M (YOY)
SENORES PHARMA: Q1 REVENUE 1.8B RUPEES VS 1.4B (YOY)
SENORES PHARMA: Q1 EBITDA 538M RUPEES VS 285M (YOY) || Q1 EBITDA MARGIN 29.8% VS 21.48% (YOY) | 1 937 |
| 4 |  Matn yo'q... | 2 230 |
| 5 | BTST KERNEX 2323 | 2 157 |
| 6 |  Matn yo'q... | 2 078 |
| 7 |  Matn yo'q... | 2 084 |
| 8 | BTST DEEPINDS 515.2 | 1 767 |
| 9 | GPTHEALTH 167 from 151 Near Second Target🔥🚀💚 | 1 830 |
| 10 | BTST THANGAMAYL 7300 | 2 146 |
| 11 | BTST PROTEAN 627.5 | 1 857 |
| 12 | BTST PPLPHARMA 192.43 | 1 967 |
| 13 | BTST PRICOL 665 | 2 070 |
| 14 | Intraday sl hit and sudden fall with increased volume 🙏 | 2 219 |
| 15 | Intraday DCAL not moved as expected exit 🙏 | 2 216 |
| 16 | KERNEX 2320 today's high
from 2133.2 till now 🔥 💚 | 2 555 |
| 17 | Yday BTST and our old Stock DEEPINDS made high of 529.45 more than 10% from previous close 🔥💚🚀 | 2 528 |
| 18 | Intraday INDOFARM 157.9 from 156.5 Near First Target Achieved till now | 2 554 |
| 19 | Intraday Buy INDOFARM cmp 156.5
Targets 158-161-164
Sl 153 | 2 589 |
| 20 | Intraday Buy INDOFARM cmp 156.5 | 2 573 |
